Navigation Links
ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
Date:12/5/2007

SAN DIEGO, Dec. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, announced today that it has completed patient enrollment in its Phase 2 clinical trial of ANX-510, or CoFactor, for the treatment of advanced breast cancer.

"Data on the primary endpoint in this study, along with overall survival data from our Phase 2b study and available data from our discontinued Phase 3 study, all of which we expect in the second quarter of 2008, will expand our understanding of CoFactor's safety and efficacy," said Evan M. Levine, chief executive officer of ADVENTRX. "By mid-next year we should have greater insight into our ability to develop CoFactor in breast cancer and other indications."

The Phase 2 clinical trial is a single arm, multicenter study to evaluate the safety and efficacy of treatment with CoFactor plus 5-fluorouracil (5-FU) in advanced breast cancer patients who have failed anthracycline and taxane chemotherapies. Patients are treated with CoFactor followed by 5-FU administered by IV bolus weekly for 6 weeks, with tumor and safety assessments every 8 weeks. The primary endpoint for the study is objective response rate as defined by Response Evaluation Criteria in Solid Tumors (RECIST) criteria, and secondary endpoints are duration of response, progression free survival, overall survival and incidence and severity of adverse events, as defined by the National Cancer Institute (NCI) Common Terminology Criteria. A total of 32 patients were enrolled in this study.

According to the American Cancer Society, breast cance
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 ... the "Pharmaceutical Contract Manufacturing - Global Strategic Business ... This report analyzes the worldwide markets for Pharmaceutical Contract ... Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms ... (Syrups, Suspensions, Gels, Creams & Ointments). The ...
(Date:8/19/2014)... , Aug. 19, 2014 Research and Markets ... by Type of Material, by Technology, by Application & by ... their offering. The demand for membranes is ... driving the market to $29.31 billion Membrane technology ... applications, such as water filtration and kidney dialysis. In modern ...
(Date:8/19/2014)... According to Kalorama Information, electronic medical records ... Data in healthcare a reality, and this a factor ... American Recovery and Reinvestment Act, the U.S. government dedicated ... penalties will start applying soon for use of paper ... study of the EMR industry, EMR 2014: The ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
(Date:8/19/2014)... Top10BestSEOHosting.com has recently announced that ... recommended suppliers for the webmasters who want to ... According to the senior spokesman for Top10BestSEOHosting.com, these ... hosting products on the market and specializes in ... of online deals when service plans are purchased ...
(Date:8/19/2014)... has recently compared many popular hosting suppliers and announced ... recommended companies for webmasters who want to buy high ... an affordable price. , Both GoDaddy and iPage ... the lowest upfront costs (including some Joomla hosting products ... of options. , GoDaddy is a famous supplier ...
(Date:8/19/2014)... News) -- Lupus and other rheumatic diseases can ... which can delay a correct diagnosis for months, ... diseases can also cause these types of symptoms, ... in Maywood, Ill. Rheumatic disorders include autoimmune ... tissues, such as lupus, systemic vasculitis and ankylosing ...
(Date:8/19/2014)... ME (PRWEB) August 19, 2014 Drews Dental ... J. Drews, D.D.S., to vice president of the Maine Dental ... MDA for three years, Dr. Drews has now been sworn ... forward to serving his term as vice president and being ... as well as the First District Caucus in 2015. He ...
(Date:8/19/2014)... August 19, 2014 Following the completion of ... Hyatt Tampa Bay is proud to debut the highly ... project included a full revamp of all public spaces to ... rooms and suites, an all-new dining experience at 1823 Kitchen ... lobby. , With the introduction of 1823 Kitchen and Bar, ...
Breaking Medicine News(10 mins):Health News:Fatcow Awarded As One of the Best Web Hosting Suppliers at Top10bestseohosting.com 2Health News:Top10BestSEOHosting.com: Cheap Joomla Hosting Reviews Unveiled 2Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:Dr. Drews Elected VP of Maine Dental Association 2Health News:Grand Hyatt Tampa Bay Hotel Unveils the Finishing Touches of Its $20 Million Makeover 2
... Hosts First Annual Exclusive Wine ... Gala, WASHINGTON, Dec. 14 Starlight Starbright,Children,s ... Annual Exclusive Wine Dinner and Eighth Annual Taste ... events were hosted at the,award-winning Michel Richard Citronelle ...
... Provides Reliable, Quick Patient-Information Retrieval From ... JOLIET, Ill., Dec. 14 AT&T Inc. ... Oncology-Hematology Associates, Ltd. (JOHA) has,awarded AT&T a ... in addition to other network solutions. Continuing ...
... 14 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... has filed suits against Watson Pharmaceuticals (NYSE:,WPI) and ... NVS ) for,infringement of the patent protecting Duramed,s ... litigation in the,U.S. District Court for the District ...
... Classification for Innovative New Treatments, AMSTERDAM, December ... product ATIR has received approval for regulatory,classification as ... Task,Force (ITF), a division of the European Medicines ... eligible for EMEA procedures. As a,next step Kiadis ...
... crowded roadways face more than 50% risk of breathing trouble, ... with asthma who are exposed to traffic pollution are at ... a study that looked at children in the Mexican border ... States. , "Major cities along the northern and southern ...
... LTC Financial Partners Offers Newsletter & Online Help for Living Longer, ... ... their,life spans, many eyeing 100-plus, the odds of needing long term care,increase. One ... says Cameron Truesdell, CEO of LTC Financial Partners,(LTCFP), "is the insurance plus health ...
Cached Medicine News:Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 2Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 3Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 4Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 2Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 3Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 2Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 3Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 4Health News:ATIR Classified as "Cell Based" Medicinal Product by the EMEA 2Health News: Traffic Pollution Hurts Asthmatic Kids' Lungs 2Health News:As More Americans Live to 100, Long Term Care Insurance Leader Gives Health Assist 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: